These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19915365)

  • 1. [Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis].
    Inaba T
    Rinsho Ketsueki; 2009 Oct; 50(10):1548-52. PubMed ID: 19915365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiation-induced and therapy-related AML/MDS].
    Inaba T
    Nihon Rinsho; 2009 Oct; 67(10):1880-3. PubMed ID: 19860183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Distinct genetic pathway in the molecular pathogenesis of MDS/AML with AML1/RUNX1 point mutations].
    Harada H
    Rinsho Ketsueki; 2007 Jul; 48(7):541-6. PubMed ID: 17695302
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.
    Ishimaru T; Hoshino T; Ichimaru M; Okada H; Tomiyasu T
    Radiat Res; 1971 Jan; 45(1):216-33. PubMed ID: 5275936
    [No Abstract]   [Full Text] [Related]  

  • 5. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 6. High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site.
    Zharlyganova D; Harada H; Harada Y; Shinkarev S; Zhumadilov Z; Zhunusova A; Tchaizhunusova NJ; Apsalikov KN; Kemaikin V; Zhumadilov K; Kawano N; Kimura A; Hoshi M
    J Radiat Res; 2008 Sep; 49(5):549-55. PubMed ID: 18724045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications in AML and MDS.
    Mahmud M; Stebbing J
    Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia.
    Matsuo T; Tomonaga M; Bennett JM; Kuriyama K; Imanaka F; Kuramoto A; Kamada N; Ichimaru M; Finch SC; Pisciotta AV
    Jpn J Clin Oncol; 1988 Jun; 18(2):91-6. PubMed ID: 2898029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial myelodysplasia and acute myeloid leukaemia--a review.
    Owen C; Barnett M; Fitzgibbon J
    Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes.
    Tsushima H; Iwanaga M; Miyazaki Y
    Int J Hematol; 2012 Mar; 95(3):232-8. PubMed ID: 22370711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular bases of myelodysplastic syndromes: lessons from animal models.
    Komeno Y; Kitaura J; Kitamura T
    J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi Anemia patient with AML1 gene amplification and monosomy 7 in pre-transplant myelodysplasia (MDS) relapsing 7 years after successful allo-SCT.
    Ayas M; Walter C
    Bone Marrow Transplant; 2008 Oct; 42(8):555-7. PubMed ID: 18622412
    [No Abstract]   [Full Text] [Related]  

  • 14. High incidence of point mutations of p53 suppressor oncogene in patients with myelodysplastic syndrome among atomic-bomb survivors: a 10-year follow-up.
    Imamura N; Abe K; Oguma N
    Leukemia; 2002 Jan; 16(1):154-6. PubMed ID: 11840277
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.
    Padmanabhan A; Baker JA; Zirpoli G; Sait SN; Ford LA; Moysich KB; Baer MR
    Leuk Res; 2008 Dec; 32(12):1820-3. PubMed ID: 18468682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML1-ETO positive AML: first report from India.
    Dutta P; Hasan SK; Sazawal S; Kumar B; Bhattacharyya J; Jain M; Tyagi S; Kumar R; Pati HP; Saxena R
    Indian J Pathol Microbiol; 2007 Jul; 50(3):652-4. PubMed ID: 17883173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on the paper: Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 May; 78(5):441-3. PubMed ID: 12020434
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiation associated leukemia and myelodysplastic syndrome].
    Kimura A
    Nihon Rinsho; 2012 Mar; 70(3):431-5. PubMed ID: 22514921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.